|
KMID : 0370220100540060529
|
|
Yakhak Hoeji
2010 Volume.54 No. 6 p.529 ~ p.534
|
|
|
Effects of 3-Phenyl-1-isoquinolinamine on the Metabolism of -Amyloid Precursor Protein in Neuroblastoma Cells
|
|
Leem Jae-Yoon
Cho Won-Jea
|
|
|
Abstract
|
|
|
|
Alzheimer’s disease (AD) is characterized pathologically by the presence of intracellular neurofibrillary tangles and deposition of -amyloid () peptides, which are generated by processing of amyloid precursor protein (APP). It is urgent to develop effective therapies for the treatment of AD, since our society rapidly accelerate aging. peptides have been believed to be neurotoxic and now are also considered to have effects on the mechanism of memory formation. Recently, we investigated that a quinoline compound from natural product reduced the secretion of from the neuroblastoma N2a cells (NL/N cell line) overexpressing APPswe. In this study, 3-phenyl-1-isoquinolinamine, a synthetic isoquinoline compound was analyzed to determine its effects on the metabolism of APP. It inhibited the secretion of peptides from the N2a NL/N cell line. Beta-site APP cleaving enzyme (BACE) fluorescence resonance energy transfer (FRET) assay revealed that it inhibited BACE activity in a dose dependent manner. Immunoblotting study showed that it inhibited APP stabilization and expression and it slightly increased the stablization and the expression of -secreatase component from the N2a NL/N cell line. We suggest that 3-phenyl-1-isoquinolinamine inhibits APP metabolism and generation by the means of BACE inhibitory mechanism. This is the first report that 3-phenyl-1-isoquinolinamine inhibits the secretion of peptides from neuroblastoma cells.
|
|
|
KEYWORD
|
|
|
Alzheimer’s disease, -amyloid peptides, APPswe, 3-phenyl-1-isoquinolinamine, BACE
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|